Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00914953 · ClinicalTrials.gov registry record · Early Phase 1
Oxytocin and Social Behavior Over the Lifespan
A Early Phase 1 study of Social Activity, sponsored by Claremont Graduate University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT00914953: Completed Early Phase 1 study of Social Activity, sponsored by Claremont Graduate University.
NCT00914953 is a Early Phase 1 study of Social Activity that has completed, run by Claremont Graduate University. The registered enrollment target is 41 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00914953, a Early Phase 1 study of Social Activity, has completed, sponsored by Claremont Graduate University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate if intranasal oxytocin (a hormone naturally produced in the body) promotes motivation for, and engagement in, social activities in older adults.
Conditions Studied
Interventions
- DRUG oxytocin (Pitocin)
Study Locations (1)
California
- Linda Valley Villa - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-12 |
| Phase | Early Phase 1 |
What the finished NCT00914953 record still lists
NCT00914953 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Social Activity appearing as the primary indexed condition, and to 1 intervention - of which oxytocin (Pitocin) is the first listed.
NCT00914953 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00914953 about?
NCT00914953 is a clinical study titled "Oxytocin and Social Behavior Over the Lifespan". This study will investigate if intranasal oxytocin (a hormone naturally produced in the body) promotes motivation for, and engagement in, social activities in older adults.
What is the current status of trial NCT00914953?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 41 participants. The study started on 2010-02. Estimated completion is 2011-12.
What conditions does trial NCT00914953 study?
This clinical trial studies the following conditions: Social Activity.
What interventions are being tested in trial NCT00914953?
The interventions under investigation include: oxytocin (Pitocin) (DRUG).
Who is sponsoring clinical trial NCT00914953?
This trial is sponsored by Claremont Graduate University, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00914953 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00914953's enrollment target sits among peer trials
41 623rd of 2000 higher than 1,373 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia